# Regulation of Plasmodium-specific CD4+ T cells

> **NIH NIH R01** · UNIVERSITY OF IOWA · 2024 · $466,500

## Abstract

PROJECT SUMMARY
Plasmodium infections and the disease malaria remain global health emergencies. Plasmodium parasites
replicate within and cause the destruction of host red blood cells, which triggers inflammation and causes the
symptoms of malarial disease. Parasite-specific antibody responses that develop following infection are critical
for controlling parasite burden and limiting disease severity. CD4+ helper T cells are essential for coordinating
these protective antibody responses. However, sterilizing anti-Plasmodium immunity rarely develops, even
following repeated infection. We hypothesize immune failures are mechanistically linked to aberrant or inefficient
Plasmodium-specific effector CD4+ T cell development and function. One of the most critical challenges to
developing new immune-based therapies or vaccines against Plasmodium is understanding the mechanisms by
which Plasmodium-specific CD4+ T cells develop, function and regulate humoral immunity following infection.
 In the continuation of this project, we apply powerful new cellular and molecular genetic approaches that
enable direct, high-resolution analyses of Plasmodium-specific CD4+ T cells. These new approaches facilitate
our long-term goal to understand the mechanisms governing the development and function of Plasmodium-
specific CD4+ T cell responses. Our goal is addressed by two specific aims that have evolved to test: 1) how
parasite-derived molecules influence cell antigen presenting functions and priming of Plasmodium-specific CD4+
T populations; and 2) how host physiological perturbations and constraints on cellular metabolism regulate CD4+
T cell development and function. Our innovative conceptual and technical advances and mechanistic approaches
enable us to establish additional new paradigms for understanding and enhancing CD4+ T cell-dependent anti-
Plasmodium immunity. Understanding cellular and molecular events governing CD4 T+ T cell responses during
malaria will enable us to identify and develop new immune-based strategies to limit Plasmodium pathogenesis
and disease burden.

## Key facts

- **NIH application ID:** 10775832
- **Project number:** 5R01AI127481-08
- **Recipient organization:** UNIVERSITY OF IOWA
- **Principal Investigator:** Noah Sullivan Butler
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $466,500
- **Award type:** 5
- **Project period:** 2016-09-26 → 2028-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10775832

## Citation

> US National Institutes of Health, RePORTER application 10775832, Regulation of Plasmodium-specific CD4+ T cells (5R01AI127481-08). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10775832. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*